Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) was the target of some unusual options trading activity on Tuesday. Stock traders acquired 29,728 call options on the stock. This represents an increase of approximately 2,219% compared to the typical volume of 1,282 call options.
Healthpeak Properties Price Performance
Shares of Healthpeak Properties stock opened at $16.81 on Thursday. The stock has a market capitalization of $11.69 billion, a price-to-earnings ratio of 168.16, a P/E/G ratio of 8.94 and a beta of 1.12. The firm’s 50-day moving average price is $17.25 and its two-hundred day moving average price is $17.53. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. Healthpeak Properties has a 1-year low of $15.71 and a 1-year high of $20.52.
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The company had revenue of $719.40 million during the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. Healthpeak Properties’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. CoreCap Advisors LLC increased its position in Healthpeak Properties by 22.4% in the 3rd quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock valued at $64,000 after acquiring an additional 613 shares in the last quarter. Fiduciary Trust Co lifted its position in shares of Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after purchasing an additional 644 shares in the last quarter. Patton Fund Management Inc. lifted its position in shares of Healthpeak Properties by 5.2% during the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after purchasing an additional 648 shares in the last quarter. Arjuna Capital grew its stake in shares of Healthpeak Properties by 4.8% during the third quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock valued at $283,000 after purchasing an additional 679 shares during the last quarter. Finally, Venture Visionary Partners LLC grew its stake in shares of Healthpeak Properties by 4.8% during the third quarter. Venture Visionary Partners LLC now owns 15,455 shares of the real estate investment trust’s stock valued at $296,000 after purchasing an additional 703 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. The Goldman Sachs Group assumed coverage on Healthpeak Properties in a research note on Friday, January 9th. They set a “neutral” rating and a $17.00 price target on the stock. Evercore reduced their price objective on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Jefferies Financial Group lowered Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Finally, Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research report on Monday, January 5th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $19.42.
Read Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Further Reading
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
